16-55823658-C-T
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001025195.2(CES1):c.431G>A(p.Gly144Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.01 in 151,662 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as drug response (★★★).
Frequency
Consequence
NM_001025195.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CES1 | NM_001025195.2 | c.431G>A | p.Gly144Glu | missense_variant | Exon 4 of 14 | ENST00000360526.8 | NP_001020366.1 | |
| CES1 | NM_001025194.2 | c.428G>A | p.Gly143Glu | missense_variant | Exon 4 of 14 | NP_001020365.1 | ||
| CES1 | NM_001266.5 | c.428G>A | p.Gly143Glu | missense_variant | Exon 4 of 14 | NP_001257.4 | ||
| CES1 | XM_005255774.3 | c.431G>A | p.Gly144Glu | missense_variant | Exon 4 of 14 | XP_005255831.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0100 AC: 1519AN: 151544Hom.: 0 Cov.: 39 show subpopulations
GnomAD2 exomes AF: 0.0109 AC: 2725AN: 249588 AF XY: 0.0112 show subpopulations
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0119 AC: 17324AN: 1450200Hom.: 0 Cov.: 35 AF XY: 0.0120 AC XY: 8645AN XY: 721462 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
Age Distribution
GnomAD4 genome AF: 0.0100 AC: 1519AN: 151662Hom.: 0 Cov.: 39 AF XY: 0.00930 AC XY: 690AN XY: 74154 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
Age Distribution
ClinVar
Submissions by phenotype
not provided Pathogenic:1Benign:1
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
CES1: PM1, PS4:Moderate, PP4, PS3:Supporting -
clopidogrel response - Efficacy Other:1
PharmGKB Level of Evidence 2B: Variants in Level 2B clinical annotations are not in PharmGKB’s Tier 1 VIPs. These clinical annotations describe variant-drug combinations with a moderate level of evidence supporting the association. For example, the association may be found in multiple cohorts, but there may be a minority of studies that do not support the majority assertion. Level 2B clinical annotations must be supported by at least two independent publications. Drug-variant association: Efficacy
clopidogrel response - Metabolism/PK Other:1
PharmGKB Level of Evidence 2B: Variants in Level 2B clinical annotations are not in PharmGKB’s Tier 1 VIPs. These clinical annotations describe variant-drug combinations with a moderate level of evidence supporting the association. For example, the association may be found in multiple cohorts, but there may be a minority of studies that do not support the majority assertion. Level 2B clinical annotations must be supported by at least two independent publications. Drug-variant association: Metabolism/PK
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at